Pendulum D2D Glucose Control for Adults With Type 2 Diabetes

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 15, 2021

Primary Completion Date

February 14, 2022

Study Completion Date

June 14, 2022

Conditions
Type2 DiabetesGastrointestinal Symptoms
Interventions
DIETARY_SUPPLEMENT

Pendulum Glucose Control formulation for T2D

"All bacteria contained in the study product formulation are commensal organisms that have been repeatedly documented to inhabit the human GI tract under normal circumstances. Pendulum's Glucose Control Formulation consists of five human commensal microbial strains including butyrate producing and mucin-degrading strains. The organisms were grown under controlled conditions consistent with Good Manufacturing Practices (GMP) and employ no animal-derived products. All ingredients utilized during manufacturing were food grade and qualified as generally recognized as safe (GRAS).~The product is provided as acid-resistant capsules in bottles that are to be stored refrigerated at 4℃."

Trial Locations (1)

90211

USC Westside Center for Diabetes, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pendulum Therapeutics

INDUSTRY

lead

University of Southern California

OTHER